FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine and pharmacology, and can be used for blood system disturbance associated with experimental neurotic affects. For this purpose, animals are preliminary divided in well and badly trained based on conditional skill training results. Then 5 mines before neurotic affect sympatholytic reserpine is singly intraperitoneally introduced. Thus well trained mice are taken dose 1 mg/kg, while badly trained mice are taken 2 mg/kg. Method provides improved efficiency of reserpine and safe therapy of blood system disturbance due to registration of individually-typological features of higher nervous activity defining mechanism specificity and medicinal agent metabolism.
EFFECT: development of effective method of therapy for blood system disturbance associated with experimental neurotic affects.
5 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR STUDYING HEMOPOIESIS WITH INDIVIDUAL HIGHER NERVOUS ACTIVITY SPECIFIC BEING TAKEN INTO ACCOUNT | 2006 |
|
RU2317541C1 |
METHOD OF GRANULOCYTOPOIESIS DEPRESSION CORRECTION IN CYTOSTATIC ACTION | 2008 |
|
RU2366422C1 |
METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
MEDICAL PRODUCTS FOR ANEMIA PREVENTION AND TREATMENT WITHIN NEUROTIC AFFECTS | 2006 |
|
RU2329035C1 |
AGENT POSSESSING ANTI-INFLAMMATORY AND ANTIFIBROTIC ACTION IN PULMONARY TISSUE, AND CYTOSTATIC ACTION | 2012 |
|
RU2479312C1 |
METHOD FOR SIMULATING CHRONIC CYTOSTATIC MYELOSUPPRESSION | 2012 |
|
RU2488890C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
MEDICINE CAPABLE OF SELECTIVELY STIMULATING GRANULO-MONOCYTOPOIESIS IN CASE OF HYPOPLASIA OF MEDULLARY HEMOPOIESIS TRIGGERED BY CYTOSTATIC | 1988 |
|
RU2020936C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
Authors
Dates
2008-07-27—Published
2006-09-25—Filed